ResMed Inc. reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was USD 1,196.98 million compared to USD 1,116.9 million a year ago. Net income was USD 300.49 million compared to USD 232.5 million a year ago. Basic earnings per share from continuing operations was USD 2.04 compared to USD 1.58 a year ago. Diluted earnings per share from continuing operations was USD 2.04 compared to USD 1.58 a year ago.
For the nine months, sales was USD 3,462.1 million compared to USD 3,100.94 million a year ago. Net income was USD 728.72 million compared to USD 667.89 million a year ago. Basic earnings per share from continuing operations was USD 4.96 compared to USD 4.55 a year ago. Diluted earnings per share from continuing operations was USD 4.94 compared to USD 4.53 a year ago.